Review
doi: 10.1056/NEJMra013339.
Imatinib mesylate--a new oral targeted therapy
Affiliations
- PMID: 11870247
- DOI: 10.1056/NEJMra013339
Item in Clipboard
Review
Imatinib mesylate--a new oral targeted therapy
N Engl J Med.
.
No abstract available
Comment in
-
Imatinib and chronic-phase leukemias.N Engl J Med. 2002 Jul 4;347(1):67-8. doi: 10.1056/NEJM200207043470116. N Engl J Med. 2002. PMID: 12097546 No abstract available.
Similar articles
-
Is imatinib a cost-effective treatment for newly diagnosed chronic myeloid leukemia patients?Nat Clin Pract Oncol. 2005 Mar;2(3):126-7. doi: 10.1038/ncponc0110. Nat Clin Pract Oncol. 2005. PMID: 16264901 No abstract available.
-
Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase.Clin Ther. 2004 Nov;26(11):1924-33. doi: 10.1016/j.clinthera.2004.11.007. Clin Ther. 2004. PMID: 15639704
-
Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).Ann Hematol. 2004;83 Suppl 1:S65-6. doi: 10.1007/s00277-004-0850-2. Ann Hematol. 2004. PMID: 15124676 Review. No abstract available.
-
Gleevec (STI-571) for chronic myeloid leukemia.Med Lett Drugs Ther. 2001 Jun 11;43(1106):49-50. Med Lett Drugs Ther. 2001. PMID: 11402258 No abstract available.
-
The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: a systematic review.Health Technol Assess. 2002;6(33):1-162. doi: 10.3310/hta6330. Health Technol Assess. 2002. PMID: 12633529 No abstract available.
Cited by
-
A Study of the Identification, Fragmentation Mode and Metabolic Pathways of Imatinib in Rats Using UHPLC-Q-TOF-MS/MS.J Anal Methods Chem. 2021 May 24;2021:8434204. doi: 10.1155/2021/8434204. eCollection 2021. J Anal Methods Chem. 2021. PMID: 34123459 Free PMC article.
-
Hepatic paraganglioma and multifocal gastrointestinal stromal tumor in a female: Incomplete Carney triad.World J Gastrointest Surg. 2013 Jul 27;5(7):229-32. doi: 10.4240/wjgs.v5.i7.229. World J Gastrointest Surg. 2013. PMID: 23894692 Free PMC article.
-
Mucosal pigmentation caused by imatinib: report of three cases.Head Neck Pathol. 2012 Jun;6(2):290-5. doi: 10.1007/s12105-011-0325-4. Epub 2011 Dec 31. Head Neck Pathol. 2012. PMID: 22209988 Free PMC article.
-
Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies.PLoS One. 2010 Apr 16;5(4):e10105. doi: 10.1371/journal.pone.0010105. PLoS One. 2010. Retraction in: PLoS One. 2019 Mar 21;14(3):e0214006. doi: 10.1371/journal.pone.0214006. PMID: 20419128 Free PMC article. Retracted.
-
Metastatic chordoma with pancreatic disease and response to imatinib.BMJ Case Rep. 2022 Jan 19;15(1):e240062. doi: 10.1136/bcr-2020-240062. BMJ Case Rep. 2022. PMID: 35046072 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
